Renewable Travel Pass May Signal Annual Booster Shots for European Union
As part of an effort to reopen their borders and encourage travelers from outside of Europe, the 27 member states of the European Union (E.U.) began issuing an “E.U. Digital COVID Certificate” (EUDCC) on July 1, 2021 to people who have receive COVID vaccinations to allow freedom of movement within the region. The travel scheme, […]
Guillain-Barré Syndrome Warning Added to AstraZeneca’s Vaxzevria COVID Vaccine in Europe
The European Medicines Agency (EMA) last week added an autoimmune condition known as Guillain-Barré syndrome (GBS) as a possible side effect to the product information on AstraZeneca/Oxford University’s Vaxzevria (or “AZD1222”) experimental adenovirus vectored vaccine. GBS is a neurological disorder that causes pain, numbness, muscle weakness and sometimes paralysis.1 2 3 4 A total of […]
FDA Approves BioNTech’s Comirnaty. Pfizer COVID Shot Remains Experimental.
On Aug. 23, 2021, the U.S. Food and Drug Administration (FDA) gave full approval to a Biologics License Application (BLA) submitted by BioNTech Manufacturing GmbH of Mainz, Germany on May 18, 2021 for a biologic drug called COVID Vaccine, mRNA. The FDA gave permission to BioNTech to label the product “Comirnaty” and market it in […]
European Union Launches Digital COVID-19 Vaccine Certificate
The European Union has announced that it will be officially launching a digital COVID-19 certificate for all E.U. citizens and residents, as well as for specific categories of travelers by July 1, 2021.1 What is the Digital COVID-19 Certificate? The E.U. Digital COVID Certificate is a mobile app that provides information such as the digital […]
COVID “Health Pass” Approved by France’s Parliament
On May 12, 2021, the French National Assembly passed a bill approving the use of a COVID pass sanitaire or “health pass.” The pass, which would be in digital form or paper, would be required as of June 9 to prove an individual has either been fully vaccinated for COVID-19, recently tested negative for SARS-CoV-2 […]
Pfizer Poised to Dominate U.S. Market for COVID-19 Biologics
Last week was a bad one for COVID-19 biologics produced by Moderna, Inc. and Johnson & Johnson, Inc. (J&J). News reports began filtering out about new research from the U.S. Centers for Disease Control and Prevention (CDC), which were published on Apr. 5, 2021 in the journal JAMA and revealed that people who receive Moderna’s […]
